Kalyan Roy: Platelet Satellitism – An Important Laboratory Artifact
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“Platelet Satellitism: An Important Laboratory Artifact
What is Platelet Satellitism?
Platelet satellitism is an EDTA-dependent in vitro phenomenon in which platelets adhere to and surround neutrophils in anticoagulated blood samples.
This interaction can lead to pseudothrombocytopenia, resulting in falsely low platelet counts on automated analyzers.
Underlying Mechanism
- EDTA induces structural changes on platelet and neutrophil membranes
- These changes expose binding sites
- Circulating antibodies or plasma proteins facilitate platelet adhesion to neutrophils
Why It Matters
- Causes spurious thrombocytopenia
- May lead to unnecessary investigations or treatment if unrecognized
How to Identify It
- Review a peripheral blood smear
- Look for platelets rosetting around neutrophils
- Correlate with analyzer flags or unexpected low platelet counts
Recommended Approach
Repeat sample collection using alternative anticoagulants:
- Sodium Citrate
- Heparin
Compare platelet counts to confirm EDTA-related artifact
Associated Conditions
Platelet satellitism may be observed in:
- Autoimmune disorders (e.g., SLE)
- Chronic infections or inflammatory states
- Hematologic malignancies (e.g., leukemia, lymphoma)
- Presence of antiplatelet antibodies
Key Takeaway
Platelet satellitism is a laboratory artifact, not a true thrombocytopenia.
Awareness and proper verification are essential to avoid misdiagnosis and ensure accurate patient care.”

Stay updated with Hemostasis Today.
-
Mar 24, 2026, 15:38Does ITI Actually Work in Hemophilia B – RPTH Journal
-
Mar 24, 2026, 15:36Doaa EL Demerdash: Call for Hematologists to Support an International ITP Survey
-
Mar 24, 2026, 15:12Simon Senanu: White Blood Cell Differential Count in Clinical Interpretation
-
Mar 24, 2026, 03:17Kathaleen Schnur: Aging with Hemophilia Through a Psychosocial Lens at THSNA 2026
-
Mar 24, 2026, 02:58Pierre Sabouret: The Additive Value of CV Imaging in CVR Assessment
-
Mar 24, 2026, 02:55Shiny K Kajal: FFP as a Targeted Coagulation Therapy
-
Mar 24, 2026, 02:53Ney Carter Borges: Circadian Disruption and Melatonin Deficiency as Cardiovascular Risk Factors
-
Mar 24, 2026, 02:52Hamid Noori: Blood Transfusion Types at a Glance
-
Mar 24, 2026, 02:50Jay Herath: Fitusiran Advancing Hemophilia Care Beyond Factor Replacement